How Diversity In Therapeutic Strategies Is Expanding The Drug Discovery Toolbox
JN4123 Wuxi Therapeutic Strategies Article Final_HR_no_crops
Related Content
Antibody-targeted therapies—including antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), and degrader-antibody conjugates (DACs)—are reshaping precision medicine by enabling highly selective delivery...
VIEW RESOURCEAntibody-drug conjugates (ADCs) hold great promise as targeted cancer therapeutics, but their complex structure poses significant development and safety challenges....
VIEW RESOURCE